期刊文献+

联合维生素治疗与血管性痴呆伴高同型半胱氨酸血症的相关分析 被引量:4

下载PDF
导出
摘要 目的分析联合维生素治疗与血管性痴呆(VD)伴高同型半胱氨酸(Hcy)血症的相关性。方法选取105例VD合并高Hcy血症患者,随机分为对照组和观察组,对照组给予常规治疗,观察组在常规治疗的基础上,联合维生素(叶酸、维生素B6、维生素B12)治疗,采用智力低下状态检查(MMSE)和日常生活能力(ADL)评分进行痴呆评定,比较两组患者治疗前后血浆Hcy水平、MMSE及ADL评分。结果对照组治疗前后血浆Hcy水平、MMSE及ADL评分比较差异均无统计学意义(P〉0.05),观察组治疗前后血浆Hcy水平、MMSE及ADL评分比较差异均有统计学意义(P〈0.01)。结论联合维生素治疗可明显降低血浆Hcy水平,减轻痴呆程度。
出处 《中国医师进修杂志(内科版)》 2007年第9期48-49,共2页 Chinese Journal of Postgraduates of Medicine
  • 相关文献

参考文献6

二级参考文献13

  • 1何国军,陈俊抛,温志波,杨波,文春燕.阿尔茨海默病与血管性痴呆患者白质疏松的MRI定量研究[J].中国临床康复,2004,8(28):6066-6067. 被引量:11
  • 2张颖冬 朱志刚 等.血浆Hcy水平及MTHFR基因多态性脑梗死发病中的作用[J].神经生化通讯,2000,13(2):1-5.
  • 3Vermeulen EGJ, Stehouwer CDA, Twisk JWR, et al. Effect of homocystein lowering treatment with folic acid plus vitain B6 on progression of subclinical atherosclerosis: a randomiced, placebo-controlled trial. Lancet, 2000,355:517~22
  • 4Kruger WD, Evans AA, Wang L, et al. Polyorphisms in the CβS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine olwering by folic acid. Mol Genet Metab, 2000,May, 70(1):53~60
  • 5Homocysteine Lowering Trialists' collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br Med J, 1998,316:894-98
  • 6Homocysteine Lowering Trialists' collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Br Med J, 1998,316:894-98
  • 7Hackam DG, Peterson JG, Spence JD. Am J Hypertens, 2000,13:105-10
  • 8Hankey GJ, Eikelboom JW. Homocysteine and stroke. Curr Opin in Neurol, 2001,14:95-102
  • 9毕胜 张昱 等.阿尔茨海默病与MTHFR基因及血浆同型半胱氨酸水平的关系[J].中华神经科杂志,2000,33(6):345-345.
  • 10李月春 刘国荣 莉娜 等.高同型半胱氨酸血症与脑血管病关系研究[J].中华神经科杂志,2000,33:373-373.

共引文献33448

同被引文献23

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 2van Eldik LJ, Wainwright MS. The Janus face of glial-derived S100B:beneficial and detrimental functions in the brain. Restor Neurol Neurosci, 2003,21 ( 5-4 ) : 97-108.
  • 3Ueno T,Iguro Y,Yamamoto H,et al. Serial measurement of serum S-100B protein as a marker of cerebral damage after cardiac surgery. Ann Thorac Surg,2003,75(6) : 1892-1897.
  • 4Foerch C,Otto B,Neumann-Haefelin T,et al. Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery oeelusion. Stroke,2004,35(9) :2160-2164.
  • 5Matsui T, Mori T,Tateishi N, et al. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I: enhanced astrocytic synthesis of S100 beta in the periinfarct area precedes delayed infarct expansion. J Cereb Bloed Flow Metab, 2002,22(6):711-722.
  • 6Winocur G,Roder J,Lobaugh N. Learning and memory, in S100-beta transgenic mice:an analysis of impaired and preserved function. N eurobiol Learn Mem, 2001,75 ( 2 ) : 250-245.
  • 7Van Eldik LJ, Wain,aright MS. The janus face of glial-derived S100B: beneficial and detrimental functions in the brain [ J]. Restorative Neural Neuroseci, 2003,21 (3-4) :97-108.
  • 8Ueno T, Iguro Y, Yamamoto H, et al. Serial measurement of serum S-100B protein as a marker of cerebral damage after cardiac surgery [J]. Ann Thorac Surg, 2003,75(6) :1892-1897.
  • 9Foerch C, Otto B, Neumann-Haefelin T, et al. Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral 'artery occlusion [ J ]. Stroke, 2004,35 ( 9 ) : 2160-2164.
  • 10Matsui T, Moil T, Tateishi N, et al. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats[J]. J Cereb Blood Flow Metab, 2002,22 (6) :711-722.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部